A compound produced by gut bacteria could play a vital role in managing and preventing type 2 diabetes, according to a study led by researchers from Imperial College London (ICL).…
Imperial-led team uncovers TMA’s role in blunting inflammation and improving metabolic health. Our work opens exciting possibilities with kinases as a new repertoire of targets accessible by microbiome-based therapeutic interventions…
An international group of scientists led by Professor Marc-Emmanuel Dumas at Imperial College London & CNRS, along with Prof. Patrice Cani (Imperial & University of Louvain, UCLouvain), Dr. Dominique Gauguier…
Credit: Pixabay/CC0 Public Domain An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine (TMA). Published…
Scientific breakthroughs in one disease don’t always shed light on treating other diseases. But that’s been the surprising journey of one Mayo Clinic research team. After identifying a sugar molecule…